Literature DB >> 17086105

Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model.

Monica Garcia-Alloza1, Sarah A Dodwell, Melanie Meyer-Luehmann, Bradley T Hyman, Brian J Bacskai.   

Abstract

Alzheimer disease (AD) is characterized both by senile plaques and neurodegeneration, although the details of the relationship between the 2 are not well understood. We postulated that oxidative stress resulting from senile plaques may mediate plaques' effects on local neuronal processes. Using multiphoton microscopy, we directly demonstrate the generation of reactive oxygen species by senile plaques. After screening of several natural antioxidants ex vivo, we assessed in vivo the effect of 2 orally administered antioxidants in APPswe/PS1d9 transgenic mice. Both Ginkgo biloba extract and vitamin E reduced the oxidative stress resulting from senile plaques in vivo as monitored with intracranial imaging. Both treatments also lead to a progressive reversal of the structural changes in dystrophic neurites associated with senile plaques. These results suggest a causal relationship between plaque-associated oxidative stress and neuritic alterations and demonstrate for the first time that the focal neurotoxicity associated with the senile plaques of AD is partially reversible with antioxidant therapies. The quantitative ex vivo screen combined with in vivo monitoring of efficacy should lead to more effective clinical therapies for the prevention of oxidative stress and neurotoxicity in AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17086105     DOI: 10.1097/01.jnen.0000240468.12543.af

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  34 in total

1.  Interactions of Npc1 and amyloid accumulation/deposition in the APP/PS1 mouse model of Alzheimer's.

Authors:  Ivan A Borbon; Robert P Erickson
Journal:  J Appl Genet       Date:  2010-12-18       Impact factor: 3.240

2.  Identification of 2-oxohistidine Interacting Proteins Using E. coli Proteome Chips.

Authors:  Jun-Mu Lin; Yu-Ting Tsai; Yu-Hsuan Liu; Yun Lin; Hwan-Ching Tai; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2016-09-19       Impact factor: 5.911

3.  Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.

Authors:  Douglas R Galasko; Elaine Peskind; Christopher M Clark; Joseph F Quinn; John M Ringman; Gregory A Jicha; Carl Cotman; Barbara Cottrell; Thomas J Montine; Ronald G Thomas; Paul Aisen
Journal:  Arch Neurol       Date:  2012-07

4.  Oxidative stress and lipid peroxidation are upstream of amyloid pathology.

Authors:  Muriel Arimon; Shuko Takeda; Kathryn L Post; Sarah Svirsky; Bradley T Hyman; Oksana Berezovska
Journal:  Neurobiol Dis       Date:  2015-06-21       Impact factor: 5.996

Review 5.  Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice.

Authors:  Chun Shi; Jun Liu; Fengming Wu; David T Yew
Journal:  Int J Mol Sci       Date:  2010-01-08       Impact factor: 5.923

6.  Long-Term Mangiferin Extract Treatment Improves Central Pathology and Cognitive Deficits in APP/PS1 Mice.

Authors:  Carmen Infante-Garcia; Juan Jose Ramos-Rodriguez; Irene Delgado-Olmos; Carlos Gamero-Carrasco; Maria Teresa Fernandez-Ponce; Lourdes Casas; Casimiro Mantell; Monica Garcia-Alloza
Journal:  Mol Neurobiol       Date:  2016-07-21       Impact factor: 5.590

7.  Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice.

Authors:  Ping Yan; Adam W Bero; John R Cirrito; Qingli Xiao; Xiaoyan Hu; Yan Wang; Ernesto Gonzales; David M Holtzman; Jin-Moo Lee
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

8.  Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice.

Authors:  Monica Garcia-Alloza; Claudia Prada; Carli Lattarulo; Sara Fine; Laura A Borrelli; Rebecca Betensky; Steven M Greenberg; Matthew P Frosch; Brian J Bacskai
Journal:  J Neurochem       Date:  2009-04-08       Impact factor: 5.372

9.  Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases.

Authors:  Todd E Golde; Victor M Miller
Journal:  Alzheimers Res Ther       Date:  2009-10-12       Impact factor: 6.982

10.  Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575.

Authors:  Monica Garcia-Alloza; Meenakshi Subramanian; Diana Thyssen; Laura A Borrelli; Abdul Fauq; Pritam Das; Todd E Golde; Bradley T Hyman; Brian J Bacskai
Journal:  Mol Neurodegener       Date:  2009-05-06       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.